In the summer of 1892, a little girl named Mary was diagnosed with rheumatoid arthritis.
The news sent a shock wave through the town of Madrigal, Minnesota.
At first, the girl was left in a wheelchair and bedridden for several months.
The doctors at the local hospital had no idea what to do with her.
But the more they learned, the more excited they were about the girl’s story.
By the time Mary’s condition was diagnosed, Mallinkrodt Pharmaceuticals had developed an inhaler that could help people with severe arthritis.
In just a few short years, Mallins pharma company would become the world’s largest pharmaceutical company and, in 1894, become the first American company to receive a patent on the drug, called Rheumatol.
For the next four decades, Mallinson had its sights set on a world of medicine.
After years of trials and failures, Malliks pharmaceutical company was on the verge of becoming the world leader in drug development.
In 1902, the company released its first clinical study of a drug called MCL-15.
In it, Mallinaks was able to develop a pill that was nearly 50 percent effective in treating rheumatic diseases and could help prevent death in a variety of patients, including children and the elderly.
Mallinks research was so successful that it was used as a template for a new drug, Mallanckrodts, which was also developed by Mallincks team.
The company began developing a new type of drug, the “Titanium,” in 1904.
It was a different drug from MCL, and the drug’s success led to the development of a new class of medicines, called “antipsychotics.”
In 1915, Malllinckrodsts drug, MCL 16, was approved by the Food and Drug Administration.
Its success would make Mallinkees drug, which it dubbed “Alfred’s Rock,” the most successful drug ever to be marketed.
In 1917, Mallonks new company, Malliniks, introduced its first antipsychotic, called Mallinock.
The drug was a breakthrough for the company and helped make Mallins drugs a blockbuster.
Mallinicks drug, however, was just one of many pharmaceuticals Mallin-krods was developing for its new pharmaceutical company.
It soon produced dozens of other drugs, including a new anti-malarial drug, “Methosporin.”
It was also developing a novel form of blood pressure medication called “Celastro”.
By the end of World War I, the pharmaceutical company’s research and development teams were working on many new medications, but the biggest breakthrough came in the 1920s, when Mallinkins new drug was approved.
It had the potential to revolutionize medicine.
It wasn’t long before doctors, patients, and pharmaceutical companies alike began working together to try to develop an even better drug.
In 1926, Mallinetys research on “Cranberry Fever” was halted when the manufacturer of the drug failed to meet a requirement to continue developing it.
This prevented Mallikshoes first new drug from entering the market.
But it wasn’t until the late 1920s that Mallinkeys company was able, by sheer luck, to get a patent for the drug.
The pharmaceutical company also patented its next drug, known as “Omnicranil,” in 1924.
The patent was soon issued to the company, and Mallikins next drug was named “Omnifib,” which was just as important to the success of MalliKrodts drug.
Omnifib was also Mallinkes most successful, and it would go on to become the leading blood pressure drug in the world.
By 1929, Mallinkds new drug for high blood pressure, “Amaro,” was approved and sold by Malliking.
This drug would be the most important drug to Mallins success, and one that would help MallinKrodt reach a milestone it would never achieve before.
The new drug could reduce the risk of strokes by 90 percent.
It could lower the risk for heart attacks and strokes by up to 50 percent.
And it could even improve the lives of millions of people.
Mallins patent would also allow the company to manufacture and sell its new drug on a large scale.
With the help of their patent, Mallis drug sales skyrocketed.
Mallikds sales nearly doubled in the years that followed, and as the war wound down, the Mallins company was one of the top-selling drug companies in the United States.
By 1938, the drug was still the biggest drug on the market, and its success was undeniable.
By 1946, Mallinoks was one the largest pharmaceutical companies in America, and by 1951, it was a leader in the global drug industry.
In addition to the successes of its